Evidence map›Paper›PMID 29285277›Full record

ArticleOncotarget2017

Indirubin, a bisindole alkaloid from

Chong Jie, Zhuo Luo, Huan Chen, Min Wang, Chang Yan, Zhong-Fu Mao, Gao-Keng Xiao, Hiroshi Kurihara, Yi-Fang Li, Rong-Rong He

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Journal of pharmacopuncture · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. High-Quality Genome of the Medicinal PlantFrontiers in plant science · 2021
    Article
  11. Frontiers in pharmacology · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chong JieAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Zhuo LuoAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Huan ChenAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Min WangDepartment of Pharmacy, Hainan General Hospital, Hainan 570311, China.
Chang YanAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Zhong-Fu MaoAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Gao-Keng XiaoInstitute of Traditional Chinese Medicine & Natural Products, Jinan University, Guangzhou 510632, China.
Hiroshi KuriharaAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Yi-Fang LiAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Rong-Rong HeAnti-Stress and Health Research Center, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Jinan University · CNHainan General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

indirubininfluenza virusMAVSSTINGvirus susceptibility

Identifiers

PMID29285277
PMCPMC5739664
OpenAlexW2767679438

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.